Pharma

Pfizer, US Seal 100 Million Covid-19 Vaccine Deal With Additional 70 Million Due By June

Pfizer, US Seal 100 Million Covid-19 Vaccine Deal With Additional 70 Million Due By June

Reuters | Thursday December 24, 2020

Covid-19 vaccine: Pfizer said last week it could need the US government to help it secure some components needed to make the vaccine

Aurobindo Pharma To Make And Sell COVAXX's Covid-19 Vaccine for India, UNICEF

Aurobindo Pharma To Make And Sell COVAXX's Covid-19 Vaccine for India, UNICEF

Reuters | Thursday December 24, 2020

Covid-19 vaccine: The Indian drugmaker has non-exclusive rights to sell the shot, which is currently undergoing an early-stage trial, in several emerging markets

Tests Expected To Confirm Existing Vaccines Also Effective Against New Covid-19 Variant

Tests Expected To Confirm Existing Vaccines Also Effective Against New Covid-19 Variant

Edited by Nirmalya Sen | Wednesday December 23, 2020

In the event that the variant presents vaccine developers with an unexpected challenge, an advantage of mRNA is that scientists can quickly reengineer genetic material in the shot to match that of the mutated protein

Volume Decline Muted Pharmaceutical Market Growth In November

Volume Decline Muted Pharmaceutical Market Growth In November

Edited by Nikita Prasad | Tuesday December 22, 2020

The pharmaceutical market reported 128.3 billion total sales in November 2020 and decline in volume can be attributed to the lower sales of the acute therapy products

Where Does The World's Pharmacy Stand In The Covid-19 Vaccine Hunt?

Where Does The World's Pharmacy Stand In The Covid-19 Vaccine Hunt?

Edited by Nirmalya Sen | Monday December 21, 2020

An effective vaccine for India needs to be an affordable vaccine that can be made in large quantities and delivered easily, ideally in a single dose

Two Doses Of Oxford/AstraZeneca Vaccine Prompts Good Immune Response: Early Data Reveals

Two Doses Of Oxford/AstraZeneca Vaccine Prompts Good Immune Response: Early Data Reveals

Edited by Nirmalya Sen | Friday December 18, 2020

Data published earlier from later Phase 3 trials showed efficacy was 62 per cent for trial participants given two full doses

Amazon Eyeing This Potential $100 Million Investment In India: Report

Amazon Eyeing This Potential $100 Million Investment In India: Report

Reuters | Wednesday December 09, 2020, Bengaluru

Growth of e-pharmacies has left many traders in the country feeling threatened, who say online drugstores can contribute to medicine sales without proper verification

Pfizer Clarifies Covid-19 Vaccine Storage Concerns for India Market

Pfizer Clarifies Covid-19 Vaccine Storage Concerns for India Market

Edited by Nirmalya Sen | Monday December 07, 2020

Coronavirus vaccine update: Pfizer requires a temperature of minus 70 degrees Celsius for storage of its vaccine

UK Bets On Millions Of Pfizer-BioNTech Vaccine Doses This Year: Minister

UK Bets On Millions Of Pfizer-BioNTech Vaccine Doses This Year: Minister

Edited by Nirmalya Sen | Friday December 04, 2020

Britain has used an emergency approval process to jump ahead of the EU and US in rollout plans of the vaccine

Dr. Reddy's And RDIF Commence Clinical Trials For Sputnik V Vaccine In India

Dr. Reddy's And RDIF Commence Clinical Trials For Sputnik V Vaccine In India

Edited by Nirmalya Sen | Tuesday December 01, 2020

The clinical trials are being conducted by JSS Medical Research as the clinical research partner

AstraZeneca Sells Former Blockbuster Cholesterol Drug Crestor for $320 Million

AstraZeneca Sells Former Blockbuster Cholesterol Drug Crestor for $320 Million

Edited by Nirmalya Sen | Tuesday December 01, 2020

British drug major sold brand drug to German pharma company Gruenenthal

Dr Reddy's Isolates Data Centre Services After Cyberattack, Shares Fall 4%

Dr Reddy's Isolates Data Centre Services After Cyberattack, Shares Fall 4%

Edited by Sandeep Singh (with inputs from agencies) | Thursday October 22, 2020

Cyber-Attack: Dr Reddy's Labs said on Thursday it had isolated all its data center services as a preventive measure following a cyber-attack.

Dr Reddy's Gains On Nod To Hold Trials For Russia's COVID Vaccine In India

Dr Reddy's Gains On Nod To Hold Trials For Russia's COVID Vaccine In India

Edited by Sandeep Singh (with inputs from agencies) | Monday October 19, 2020

Dr Reddy's Share Price: The stock rose by Rs 131.15 to Rs 5,213.50 apiece on the BSE during the session, having begun the day stronger at Rs 5,202.00 compared to its previous close of Rs 5,082.35.

Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US

Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US

Edited by Sandeep Singh | Friday September 18, 2020

The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent.

Cipla Hits Record High After Strong June Quarter Earnings

Cipla Hits Record High After Strong June Quarter Earnings

Edited by Sandeep Singh (with inputs from agencies) | Monday August 10, 2020

Cipla Share Price: By 11:22 am, 6.88 lakh Cipla shares had changed hands on the BSE, as against an average of 3.49 lakh over the past two weeks.

12345...6